Tamiflu US Press Conference

Tamiflu (oseltamivir) is a neuraminidase inhibitor, developed by Roche, for the treatment of seasonal and pandemic influenza. Yet for the first time a comprehensive review of the data, by independent researchers, has shown that the claims for Tamiflu ’s effectiveness have been overestimated, and that harms have been underreported. Here is the audio...
Source: The BMJ Podcast - Category: General Medicine Authors: Source Type: podcasts